These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9672231)

  • 1. HIV type 1-specific helper T cells: a critical host defense.
    Rosenberg ES; Walker BD
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S143-7. PubMed ID: 9672231
    [No Abstract]   [Full Text] [Related]  

  • 2. Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease.
    Bronke C; Jansen CA; Westerlaken GH; De Cuyper IM; Miedema F; Tesselaar K; van Baarle D
    Clin Immunol; 2007 Aug; 124(2):190-9. PubMed ID: 17556025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-specific CD4+ T cells and viremia: who's in control?
    Jansen CA; van Baarle D; Miedema F
    Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune control of HIV-1 after early treatment of acute infection.
    Rosenberg ES; Altfeld M; Poon SH; Phillips MN; Wilkes BM; Eldridge RL; Robbins GK; D'Aquila RT; Goulder PJ; Walker BD
    Nature; 2000 Sep; 407(6803):523-6. PubMed ID: 11029005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
    Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D
    Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
    Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
    J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
    Scriba TJ; Zhang HT; Brown HL; Oxenius A; Tamm N; Fidler S; Fox J; Weber JN; Klenerman P; Day CL; Lucas M; Phillips RE
    J Clin Invest; 2005 Feb; 115(2):443-50. PubMed ID: 15668739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
    Jones LE; Perelson AS
    Bull Math Biol; 2005 Nov; 67(6):1227-51. PubMed ID: 16023709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.
    Cohen DE; Walker BD
    Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.
    Musey LK; Krieger JN; Hughes JP; Schacker TW; Corey L; McElrath MJ
    J Infect Dis; 1999 Aug; 180(2):278-84. PubMed ID: 10395840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual presentation of acute cytomegalovirus disease during primary HIV-1 infection: antigen-specific T-cell response analyses and clinical outcome.
    Capetti A; Piconi S; Magni C; Quirino T; Trabattoni D; Clerici M
    AIDS; 2006 Jul; 20(11):1566-7. PubMed ID: 16847419
    [No Abstract]   [Full Text] [Related]  

  • 15. The loss of CMV-specific CD27(-) T-cell effectors in a patient with recurrences of CMV retinitis is independent of HIV-1 viremia.
    D'Offizi G; Ciapparoni V; Gioia C; Goletti D; Agrati C; Pucillo LP; Narciso P; Poccia F
    Infection; 2002 Oct; 30(5):323-5. PubMed ID: 12382097
    [No Abstract]   [Full Text] [Related]  

  • 16. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity in HIV infection.
    Clerici M
    AIDS; 1993; 7 Suppl 1():S135-40. PubMed ID: 8363777
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
    Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
    Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.